Silence Therapeutics PLC
F:XRP2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Silence Therapeutics PLC.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Silence Therapeutics Does
Silence Therapeutics PLC is a GB-based company operating in Biotechnology industry. Silence Therapeutics plc is a global clinical-stage biotechnology company engaged in transforming people’s lives by silencing diseases through precision-engineered medicines created with proprietary siRNA (short interfering RNA) technology. The firm leverages its mRNAi GOLD platform to create siRNAs designed to precisely target and silence disease-associated genes in the liver.
- Headquarters
- United Kingdom UK
- Employees
- 88
- IPO date
- Jan 5, 2010
Balance Sheet
Continue XRP2 Research
Decided on Silence Therapeutics? Get an email when XRP2 reaches the price you’d buy at. Free with an account.